Cost profiles and budget impact of rechargeable versus non-rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome-Reference-Cited by-同舟云学术

Cost profiles and budget impact of rechargeable versus non-rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome

Published:2016-04-06 Issue:3 Volume:36 Page:727-733
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourol. Urodynam.

Author:

Noblett Karen L.¹,Dmochowski Roger R.²,Vasavada Sandip P.³,Garner Abigail M.⁴,Liu Shan⁴⁵,Pietzsch Jan B.⁴

Affiliation:

1. University of California; Riverside California

2. Vanderbilt University; Nashville Tennessee

3. Cleveland Clinic; Cleveland Ohio

4. Wing Tech, Inc.; Menlo Park California

5. University of Washington; Seattle Washington

Funder

Axonics Modulation Technologies, Inc.

Publisher

Wiley

Subject

Urology,Clinical Neurology

Reference17 articles.

1. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder;Noblett;Neurourol Urodyn,2016

2. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment;Gormley;J Urol,2015

3. Latest technologic and surgical developments in using InterStim therapy for sacral neuromodulation: Impact on treatment success and safety;Spinelli;Eur Urol,2008

4. Cost-effectiveness of sacral neuromodulation compared to botulinum neurotoxin a or continued medical management in refractory overactive bladder;Arlandis;Value Health,2011

5. Economic evaluation of sacral neuromodulation in overactive bladder: A Canadian perspective;Hassouna;Can Urol Assoc J,2015

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The urologist’s role in bowel management of adult spina bifida: a narrative review;Translational Andrology and Urology;2024-01

2. Re: Evaluation of Clinical Performance and Safety for the Rechargeable InterStim Micro Device in Overactive Bladder Subjects: 6‐month Results from the Global Postmarket ELITE Study;European Urology;2023-11

3. Long‐term cost‐effectiveness analysis of sacral neuromodulation in the treatment of severe faecal incontinence;Colorectal Disease;2023-08-07

4. Evaluation of clinical performance and safety for the rechargeable InterStim Micro device in overactive bladder subjects: 6‐month results from the global postmarket ELITE study;Neurourology and Urodynamics;2023-03-14

5. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects;Expert Review of Medical Devices;2022-02-01